Market research
MBOT Microbot Medical Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 101M
- P/E ratio
- Not available
- Analyst target
- 6.6667
- Dividend yield
- Not available
- Beta
- 1.05
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US59503A2042
- Market cap
- 101M
- P/E ratio
- Not available
- Analyst target
- 6.6667
- Dividend yield
- Not available
- Beta
- 1.05
About
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MBOT discussion.
5 years, 4 months ago
Microbot Medical Inc is currently in a long term downtrend where the price is trading 3.5% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Microbot Medical Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 100.0% to $-9 since the same quarter in the previous year.
Finally, its free cash flow grew by 357.1% to $5M since the same quarter in the previous year.
Based on the above factors, Microbot Medical Inc gets an overall score of 3/5.